Best Addiction and Substance Abuse Grants in Northern Mariana Islands

Northern Mariana Islands addiction and substance use researchers can access funding through the National Institutes of Health to test SBIRT/P approaches for alcohol, tobacco, and other drug use among adults facing health disparities. Projects must prospectively evaluate screening, brief intervention, and referral to treatment or prevention in collaboration with healthcare and community partners across eligible U.S. jurisdictions.

Research institutions and eligible organizations in the Northern Mariana Islands can apply for National Institutes of Health SBIRT/P grants to test screening, brief intervention, and referral approaches for alcohol, tobacco, and other drug use in adults experiencing health disparities. Projects must prospectively evaluate SBIRT/P and collaborate with healthcare and community partners; multiple NIH deadlines run through 2027.

The Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use initiative aims to enhance prevention services for infectious diseases among people who use drugs (PWUD). It encompasses two components: a biennial survey to assess service gaps and capacity, and increased support for testing and treatment services. The initiative seeks to improve data utilization in service provision, ultimately increasing testing for HBV, HCV, and HIV, and ensuring more PWUD engage in treatment and care.

Organizations providing research education experiences in addiction and substance use disorders in the Northern Mariana Islands can apply for up to US $1,250,000 to support skills-development courses and research experiences. Grants from National Institutes of Health help build a more inclusive biomedical and behavioral science workforce focused on substance use and related health fields.

Clinician scientists can pursue intensive training in substance use and substance use disorder research through mentored NIH career development funding. This institutional K12 program offers up to US $750,000, emphasizing addiction-focused research and supporting eligible organizations, including those in the Northern Mariana Islands and other U.S. jurisdictions.

Researchers and research teams in the Northern Mariana Islands studying HIV and substance use can apply for this NIH opportunity, with awards up to US $1,500,000 for high-priority projects. Funding supports basic, clinical, and implementation research that clearly addresses HIV/AIDS among people who use drugs, including addiction and substance use disorders.

The HEAL Initiative aims to combat the opioid crisis through action-oriented research that enhances the translation of addiction epidemiology, prevention, treatment, and recovery services into practice. It prioritizes scalable, evidence-based approaches targeting various levels, including individual and community. The initiative supports a range of methods for research deployment, emphasizing collaboration between researchers and decision-makers to improve outcomes for those affected by addiction and related chronic pain.

Rural health and substance use organizations in the Northern Mariana Islands can access funding to deliver training and technical assistance addressing opioid and stimulant misuse. Grants from the Substance Abuse and Mental Health Services Adminis support prevention, overdose prevention, treatment, and recovery services, with up to US $650,000 available for Regional Centers and a national coordinating office.

Research institutions and eligible organizations conducting addiction and substance use disorder studies in the Northern Mariana Islands can access funding through the National Institutes of Health. NIH provides Northern Mariana Islands addiction and substance use researchers with up to US $275,000 for time-sensitive pilot, feasibility, or exploratory projects on emerging drug issues, marijuana trends, prescription drug abuse, health system changes, or justice-related opportunities.

The NIH is offering access to biospecimens from the ABCD, HBCD, and PATH studies to promote research on health and disease across a lifetime. This initiative encourages projects that utilize these samples to deepen understanding of genetic and environmental influences, particularly substance exposure. Researchers can submit proposals to maximize the scientific utility of these resources, in alignment with the goals outlined under federal health regulations.

Research institutions and similar organizations studying tobacco, alcohol, or cannabis policy impacts on health equity can apply for grants up to US $275,000 from the National Institutes of Health; projects must focus on U.S. populations. Grants from NIH help Northern Mariana Islands addiction and substance use researchers engage communities to advance cancer prevention and reduce exposure-related disparities.

NIH provides Northern Mariana Islands addiction and substance use researchers with funding to study how tobacco, alcohol, and cannabis policies affect use and secondhand exposure among populations facing health disparities. Eligible U.S.-based projects, including those partnering with local community organizations, can receive up to US $2,500,000 to advance health equity and cancer prevention policy research.

The NIDA Research Education Program (R25) aims to enhance the training of a workforce skilled in biomedical, behavioral, and clinical research, particularly regarding substance use disorders. This program supports educational activities that prepare clinicians and clinical researchers. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged 30 days prior to the full proposal deadline. This initiative does not fund non-research-related clinical training.

The Chemical Countermeasures Research Program (CCRP) Initiative aims to support vital research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, including fentanyl and its combinations. This funding opportunity encourages studies that enhance understanding and mitigation strategies for these substances, focusing on both immediate and long-term health impacts. Applications are due by 5:00 PM local time, with optional Letters of Intent accepted 30 days prior to the proposal deadline.

Research institutions and qualified organizations working on addiction, substance use, alcohol use, or mental health treatment can apply for NIH funding to advance drug, device, and neurostimulation therapies, including in the Northern Mariana Islands. Focused on translational neuroscience and pharmacology, the U01 mechanism supports discrete projects from discovery through preclinical and proof-of-concept stages, with academia–industry partnerships encouraged.

Research institutions and multidisciplinary teams in the Northern Mariana Islands and other U.S. locations can seek NIH funding to develop and test new drugs, devices, and neurostimulation approaches for mental, substance use, and alcohol use disorders. US Dept. of Health & Human Services: National Institutes of Health supports multi-project cooperative programs advancing discovery through proof-of-concept stages.

Research institutions and eligible organizations conducting addiction and substance use disorder research in the Northern Mariana Islands and other U.S. jurisdictions can apply for NIH’s HEAL R61/R33 funding, with awards up to US $750,000. Grants from National Institutes of Health help translate epidemiology, prevention, treatment, and recovery findings into scalable, real-world practice to reduce overdose and substance misuse.

Research institutions and eligible organizations in Northern Mariana Islands can apply for US Dept. of Health & Human Services: National Institutes of Health grants, awarding up to US $3,000,000 for developing medications and interventions to prevent and treat substance use disorders and overdose. Projects may include preclinical or clinical pharmacology studies addressing addiction and drug use disorders.

The Drug-Free Communities (DFC) Support Program, initiated by the Drug-Free Communities Act of 1997, aims to bolster community coalitions dedicated to preventing youth substance use. Funded by the US HHS's Substance Abuse and Mental Health Services Administration (SAMHSA), this program focuses on collaboration among various stakeholders, including government and non-profit entities, to effectively reduce substance abuse among youth and promote protective factors within communities.

The Drug-Free Communities (DFC) Support Program aims to foster collaboration among community coalitions to combat youth substance use. Established by the Drug-Free Communities Act of 1997, it encourages partnerships among various stakeholders, including governmental and non-profit agencies. The program focuses on reducing substance use among youth and promoting protective factors within communities. This funding opportunity is available for those who have completed the initial funding cycle or experienced funding interruptions, supporting their ongoing efforts to create a healthier environment for youth.

The Residential Treatment for Pregnant and Postpartum Women program aims to deliver essential services to women facing substance use disorders. By offering comprehensive residential treatment options, the program supports both recovery and the well-being of mothers and their children. Funded by the Substance Abuse and Mental Health Services Administration, this initiative addresses the unique challenges of pregnant and postpartum women, ensuring they receive the care necessary for a successful recovery journey.

The Rural Communities Opioid Response Program - Overdose Response aims to enhance healthcare access in rural areas by addressing urgent needs related to substance use disorder services. This initiative focuses on reducing overdose risks through targeted interventions and support, ensuring that rural communities receive necessary assistance. Funded by the Health Resources and Services Administration, this program is crucial for mitigating the opioid crisis in underserved regions, improving health outcomes, and promoting overall community well-being.

The Rural Communities Opioid Response Program focuses on enhancing behavioral health care services for children and adolescents in rural areas. By providing essential funding, this initiative aims to tackle mental health and substance use disorders, ensuring that young individuals receive the support they need. The program, administered by the Health Resources and Services Administration, is crucial in addressing the unique challenges faced by rural communities, promoting healthier outcomes for future generations.

The NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA) aims to renew support for two research consortia focusing on the biological mechanisms of excessive alcohol consumption and Alcohol Use Disorder (AUD). By utilizing advanced technologies and fostering collaboration across multiple sites, this initiative seeks to standardize neurofunctional measures and enhance reproducibility in findings. Investigators are encouraged to prepare for future applications to this NOFO, which will utilize the U24 activity code.

The HEAL Initiative: Pain Research Enhancement Program (PREP) supports R15-eligible Principal Investigators in conducting innovative pain research. This program encourages interdisciplinary partnerships and aims to enhance the research environment for health professional trainees. Key application deadlines include November 19, 2024, and October 28, 2025, with specific dates for AIDS-related applications. By fostering collaboration, the initiative seeks to advance understanding and treatment of pain.

The Rapid Response Opioid and Pain Management ECHO Funding Opportunity by the Association of State and Territorial Health Officials (ASTHO) aims to enhance clinician training in effective pain management strategies. This initiative focuses on non-opioid treatments, substance use screening, and risk reduction counseling, promoting compassionate care while addressing public health challenges and ensuring continuity for patients affected by prescription disruptions. The program seeks to improve overall health outcomes and reduce risks associated with opioid use.